Biopharmaceutical Company.
Trans Pacific Partnership agreement, with respect to data exclusivity for biologics. H.R. 9: Innovation Act, including proposed changes to the Inter Partes Review (IPR) process at the Patent and Trademark Office (PTO). H.R. 6: 21st Century Cures Act.

H.R. 3537: Synthetic Drug Control Act of 2015.

H.R. 1786: "James Zadroga 9/11 Health and Compensation Reauthorization Act" with respect to potential budgetary offsets. Education on the importance of maintaining the competitive elements of the Part D prescription drug program and to oppose efforts to impose mandatory government rebates in that program and proposed changes to cost sharing for low income seniors. P.L. 114-74, "Bipartisan Budget Act of 2015".
TRD - Trade (domestic/foreign) CPT - Copyright/Patent/Trademark HCR - Health Issues MMM - Medicare/Medicaid BUD - Budget/Appropriations
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
W STRATEGIES, LLC
1455 Pennsylvania Avenue, NW, Suite 400, Washington, DC, 20004, US
DARREN WILLCOX DARREN WILLCOX DARREN WILLCOX DARREN WILLCOX DARREN WILLCOX